WILMINGTON, Delaware, Dec. 12 (TNSres) -- AstraZeneca, a biopharmaceutical company, issued the following news release: * * * 87.5% of patients treated with LYNPARZA were alive at six years vs. 83.2% in the comparator arm First and only PARP inhibitor to improve survival in early breast cancer * * * Updated results from the OlympiA Phase III trial showed AstraZeneca and Merck & Co., Inc's, known as MSD outside of the US and Canada, LYNPARZA (olaparib) demonstrated sustained, clinically mean more PR

WASHINGTON, Dec. 12 (TNSres) -- Groundwork Collaborative, a think tank and progressive advocacy group, issued the following news release on Dec. 11, 2024: * * * Today, the Bureau of Labor Statistics released the November Consumer Price Index, which shows inflation at 2.7% year-over-year. Groundwork Collaborative Executive Director Lindsay Owens reacted with the following statement: "With food prices rising, the last thing consumers need is less competition in the grocery sector. The Federal more PR

WASHINGTON, Dec. 12 -- The Judicial Panel on Multidistrict Litigation issued the following order (MDL No. 3026) on Dec. 11, 2024: * * * In Re: Abbott Laboratories, et al., Preterm Infant Nutrition Products Liability Litigation TRANSFER ORDER Before the Panel: Plaintiff in the Northern District of California Sudds action listed on the attached Schedule A moves under Panel Rule 7.1 to vacate the Panel's order conditionally transferring the action to MDL No. 3026. Defendant Abbott Laboratories  more PR

ALBANY, New York, Dec. 12 -- The New York State Department of Health issued the following news release: * * * The 9th Annual Ending the Epidemic Summit and 26th World AIDS Day Theme is Titled, "Unraveling Syndemics: A Community Response, Shared Solutions" Panels of the AIDS Memorial Quilt Will be On Display Summit Highlights Progress Toward Ending the Epidemic Goals and 2023 Surveillance Report * * * The New York State Department of Health's 9th annual Ending the Epidemic (ETE) Summit and  more PR